Molecular docking reveals ivermectin and remdesivir as potential repurposed drugs against SARS-CoV-2
AF Eweas, AA Alhossary… - Frontiers in Microbiology, 2021 - frontiersin.org
SARS-CoV-2 is a newly emerged coronavirus that causes a respiratory disease with
variable severity and fatal consequences. It was first reported in Wuhan and subsequently …
variable severity and fatal consequences. It was first reported in Wuhan and subsequently …
Synthesis, characterization and molecular docking of new nucleosides and Schiff bases derived from ampyrone as antiviral agents to contain the COVID-19 virus
SH Alotaibi, HH Amer, N Touil… - Polycyclic Aromatic …, 2023 - Taylor & Francis
A new series of nucleoside derivatives was prepared from the reaction of 4-aminoantipyrene
with different sugar moieties. In addition, ampyrone's reaction with different aromatic …
with different sugar moieties. In addition, ampyrone's reaction with different aromatic …
SARS-CoV-2: a villain virus that causes COVID-19 pandemic
AS ABDEL-MONEIM - Moroccan Journal of Public Heath, 2020 - revues.imist.ma
The SARS-CoV-2 was first isolated fromcases of severe pneumonia in Wuhan city, Hubei
province, China in December 2019 (Zhou et al., 2020). On 11 March, SARS-CoV-2 was …
province, China in December 2019 (Zhou et al., 2020). On 11 March, SARS-CoV-2 was …